JP2024514026A5 - - Google Patents
Info
- Publication number
- JP2024514026A5 JP2024514026A5 JP2024506588A JP2024506588A JP2024514026A5 JP 2024514026 A5 JP2024514026 A5 JP 2024514026A5 JP 2024506588 A JP2024506588 A JP 2024506588A JP 2024506588 A JP2024506588 A JP 2024506588A JP 2024514026 A5 JP2024514026 A5 JP 2024514026A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- item
- composition
- antigen
- lpc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163173958P | 2021-04-12 | 2021-04-12 | |
| US63/173,958 | 2021-04-12 | ||
| US202163246740P | 2021-09-21 | 2021-09-21 | |
| US63/246,740 | 2021-09-21 | ||
| PCT/US2022/071664 WO2022221827A2 (en) | 2021-04-12 | 2022-04-11 | Hyperactivators of mammalian dendritic cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514026A JP2024514026A (ja) | 2024-03-27 |
| JP2024514026A5 true JP2024514026A5 (enExample) | 2025-04-21 |
Family
ID=81749254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506588A Pending JP2024514026A (ja) | 2021-04-12 | 2022-04-11 | 哺乳類の樹状細胞の過剰活性化因子 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240197869A1 (enExample) |
| EP (1) | EP4322999A2 (enExample) |
| JP (1) | JP2024514026A (enExample) |
| AU (1) | AU2022257111A1 (enExample) |
| CA (1) | CA3215072A1 (enExample) |
| IL (1) | IL307508A (enExample) |
| WO (1) | WO2022221827A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118843455A (zh) * | 2022-02-07 | 2024-10-25 | 科纳治疗公司 | 免疫原性mRNA递送媒介物 |
| TW202342094A (zh) * | 2022-02-07 | 2023-11-01 | 美商科納療法股份有限公司 | 高度活化之脂質奈米粒子 |
| WO2024159157A2 (en) * | 2023-01-27 | 2024-08-02 | Corner Therapeutics, Inc. | Phospholipid analogs for hyperactivation of mammalian dendritic cells |
| TW202502377A (zh) * | 2023-03-13 | 2025-01-16 | 美商科納療法股份有限公司 | 旁觀者抗原增強之腫瘤細胞溶解物免疫原性 |
| WO2025221606A1 (en) * | 2024-04-16 | 2025-10-23 | Corner Therapeutics, Inc. | Lipids for hyperactivation of mammalian dendritic cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2836828A1 (fr) * | 2002-03-11 | 2003-09-12 | Bio Merieux | Utilisation de l-alpha-lysophosphatidylcholine pour obtenir la differenciation de monocytes en cellules dendritiques matures in vitro |
| WO2004091603A1 (fr) * | 2003-04-07 | 2004-10-28 | Clinigenetics | Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires |
| CN102293743B (zh) * | 2010-06-24 | 2013-09-18 | 辽宁成大生物股份有限公司 | 一种脂质微球组合物 |
| KR101951933B1 (ko) * | 2013-03-12 | 2019-02-25 | 주식회사 아리바이오 | 라이소포스파티딜콜린 또는 이의 유도체를 포함하는 지질나노물질 및 이의 제조방법 |
-
2022
- 2022-04-11 WO PCT/US2022/071664 patent/WO2022221827A2/en not_active Ceased
- 2022-04-11 EP EP22724603.0A patent/EP4322999A2/en active Pending
- 2022-04-11 AU AU2022257111A patent/AU2022257111A1/en active Pending
- 2022-04-11 CA CA3215072A patent/CA3215072A1/en active Pending
- 2022-04-11 US US18/286,333 patent/US20240197869A1/en active Pending
- 2022-04-11 JP JP2024506588A patent/JP2024514026A/ja active Pending
- 2022-04-11 IL IL307508A patent/IL307508A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024514026A5 (enExample) | ||
| US10729766B2 (en) | Method for improving the efficacy of a survivin vaccine in the treatment of cancer | |
| US9931378B2 (en) | Method of immunotherapy for treatment of human papillomavirus infection | |
| US20240197869A1 (en) | Hyperactivators of mammalian dendritic cells | |
| JPH09511737A (ja) | 免疫治療剤とその使用 | |
| Bhardwaj et al. | TLR agonists: Are they good adjuvants? | |
| KR20190122717A (ko) | 면역 증강제, 면역치료 약학적 조성물 및 이의 제조 및 용도 | |
| EP1727563B1 (fr) | Procede pour amplifier l'activite de vaccins therapeutiques | |
| CN119185520A (zh) | 一种仿生自噬小体的肿瘤纳米疫苗及其制备方法与应用 | |
| TW202345909A (zh) | 免疫原性mRNA遞送載體 | |
| US20180360738A1 (en) | Anti-infection and anti-tumor mucosal immune preparation | |
| US20250127868A1 (en) | Hyperactivating lipid nanoparticles | |
| TW202400253A (zh) | 編碼具持續性活性之環gmp-amp合成酶之核酸及用於彼等之免疫原性遞送載體 | |
| JP2018070629A (ja) | がんの処置におけるサバイビンワクチンの有効性を向上させるための方法 | |
| HK40041061A (en) | Method for improving the efficacy of a survivin vaccine in the treatment of cancer | |
| EP3000471A1 (en) | Novel immunostimulatory molecules | |
| WO2024192034A2 (en) | Bystander antigen enhancement of tumor cell lysate immunogenicity | |
| CN120865360A (zh) | 一种eb病毒相关抗原长肽及其应用 | |
| CN119950697A (zh) | 一种佐剂及其制备方法和用途 | |
| HK1240504B (zh) | 逆转朗格汉斯细胞免疫抑制的方法 | |
| HK1220914B (en) | Method for improving the efficacy of a survivin vaccine in the treatment of cancer |